Literature DB >> 25592222

Association of single-nucleotide polymorphisms in the IRF6 gene with non-syndromic cleft lip with or without cleft palate in the Xinjiang Uyghur population.

Ainiwaer Mijiti1, Wang Ling1, Adili Moming2.   

Abstract

Our main aim was to investigate the association between the interferon regulatory factor (IRF6) gene and non-syndromic cleft lip and palate (nsCLP) in the Xinjiang Uyghur population. Twelve single nucleotide polymorphisms (SNP) were screened in a group of 100 patients with nsCLP and in a control group of 60 unaffected subjects by next generation sequencing using a MiSeq Benchtop Sequencer (Illumina). Our case-control association analysis showed that the SNP marker rs7545538 differed significantly in genotype (codominant model; CC compared with CG compared with GG; p=0.038) and allele frequencies (odds ratio (OR)=1.89, 95% CI 1.18-3.03, p=0.007) between patients with nsCLP and controls. Analysis of the recessive model of inheritance showed that distribution of the recessive model of rs7545538 (GG compared with CC+GC) was significantly higher in patients with nsCLP than in controls (OR=2.5, 95% CI 1.13-5.37, p=0.021) and had a borderline association with an increased risk of nsCLP (OR=2.5, 95% CI 1.13-5.37, p=0.021). Markers rs2235377 and rs2235371 also differed significantly in dominant and over-dominant models of inheritance (p=0.037) while increased G allele frequency was seen in SNP rs2235373 (p=0.03). A haplotype analysis showed four common haplotypes in Block 1: CCGGT>CCGAT>CACAT>TAGAC (in frequency). The 5-marker combination haplotype CCGAT was significantly more common in patients with nsCLP than in controls (p=0.032). In Block 2, the overall distribution of the haplotypes TAC and TAG predicted by the three SNP differed significantly between the patients with nsCLP and control subjects (p=0.009 and 0.003, respectively). Our results showed that genetic polymorphism of the IRF6 gene is associated with increased risk of nsCLP in a Xinjiang Uyghur population.
Copyright © 2014 The British Association of Oral and Maxillofacial Surgeons. Published by Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  Case–control study; IRF6 gene; Linkage disequilibrium; Orofacial clefts

Mesh:

Substances:

Year:  2015        PMID: 25592222     DOI: 10.1016/j.bjoms.2014.12.008

Source DB:  PubMed          Journal:  Br J Oral Maxillofac Surg        ISSN: 0266-4356            Impact factor:   1.651


  5 in total

Review 1.  Genomic expression in non syndromic cleft lip and palate patients: A review.

Authors:  D Mehrotra
Journal:  J Oral Biol Craniofac Res       Date:  2015-05-21

Review 2.  Association between IRF6 and 8q24 polymorphisms and nonsyndromic cleft lip with or without cleft palate: Systematic review and meta-analysis.

Authors:  Kachin Wattanawong; Sasivimol Rattanasiri; Mark McEvoy; John Attia; Ammarin Thakkinstian
Journal:  Birth Defects Res A Clin Mol Teratol       Date:  2016-08-11

3.  Histological and Immunohistochemical Studies to Determine the Mechanism of Cleft Palate Induction after Palatal Fusion in Mice Exposed to TCDD.

Authors:  Chisato Sakuma; Hideto Imura; Tomohiro Yamada; Azumi Hirata; Yayoi Ikeda; Masaaki Ito; Nagato Natsume
Journal:  Int J Mol Sci       Date:  2022-02-13       Impact factor: 5.923

4.  Association of Transforming Growth Factor Alpha Polymorphisms with Nonsyndromic Cleft Lip and Palate in Iranian Population.

Authors:  Asghar Ebadifar; Roya Hamedi; Hamid Reza Khorram Khorshid; Kioomars Saliminejad; Koorosh Kamali; Fatemeh Aghakhani Moghadam; Nazanin Esmaeili Anvar; Nazilla Ameli
Journal:  Avicenna J Med Biotechnol       Date:  2015 Oct-Dec

5.  Association of single nucleotide polymorphisms in AXIN2, BMP4, and IRF6 with Non-Syndromic Cleft Lip with or without Cleft Palate in a sample of the southeast Iranian population.

Authors:  Houshang Rafighdoost; Mohammad Hashemi; Hiva Danesh; Fatemeh Bizhani; Gholamreza Bahari; Mohsen Taheri
Journal:  J Appl Oral Sci       Date:  2017 Nov-Dec       Impact factor: 2.698

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.